Search Within

Robert Motzer

Formats
  1. Journal Article (609)
  2. Meeting Abstract (578)
  3. Book Section (20)
  4. Review (13)
  5. Conference Paper (6)
  6. Correspondence (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (3)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1247)
  2. Genitourinary Oncology Service (1247)
  3. Solid Tumor Oncology Division (1247)
  4. Surgery (290)
  5. Urology (281)
  6. Survivorship Research (253)

More Groups

People
  1. George Bosl (182)
  2. Martin Voss (178)
  3. Darren Feldman (158)
  4. Dean Bajorin (128)
  5. Paul Russo (119)
  6. Joel Sheinfeld (110)

More People

Years
  1. 2025 (30)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (448)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (451)
  2. Elsevier Science, Inc. (111)
  3. Oxford University Press (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (86)
  6. American Association for Cancer Research (58)

More Publishers

Results (1247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort
    Meeting Abstract

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma
    Meeting Abstract

    Carlo, M. I.; Attalla, K.; Patil, S.; Murray, S. J.; Chen, Y. B.; Kotecha, R.; Durack, J. C.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial
    Meeting Abstract

    Cella, D.; Choueiri, T. K.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Zhang, J.; Ivanescu, C.; Motzer, R. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: An emerging entity with variable clinical course
    Journal Article

    DiNatale, R. G.; Gorelick, A. N.; Makarov, V.; Blum, K. A.; Silagy, A. W.; Freeman, B.; Chowell, D.; Marcon, J.; Mano, R.; Sanchez, A.; more...
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of atezolizumab plus bevacizumab following disease progression on atezolizumab or sunitinib monotherapy in patients with metastatic renal cell carcinoma in IMmotion150: A randomized phase 2 clinical trial
    Journal Article

    Powles, T.; Atkins, M. B.; Escudier, B.; Motzer, R. J.; Rini, B. I.; Fong, L.; Joseph, R. W.; Pal, S. K.; Sznol, M.; Hainsworth, J.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Atezolizumab plus bevacizumab versus sunitinib for patients with untreated metastatic renal cell carcinoma and sarcomatoid features: A prespecified subgroup analysis of the IMmotion151 clinical trial
    Journal Article

    Rini, B. I.; Motzer, R. J.; Powles, T.; McDermott, D. F.; Escudier, B.; Donskov, F.; Hawkins, R.; Bracarda, S.; Bedke, J.; De Giorgi, U.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma
    Journal Article

    Motzer, R.; Alekseev, B.; Rha, S. Y.; Porta, C.; Eto, M.; Powles, T.; Grünwald, V.; Hutson, T. E.; Kopyltsov, E.; Méndez-Vidal, M. J.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Prognosis of incidental brain metastases in patients with advanced renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Flippot, R.; Nortman, T.; Guida, A.; Patil, S.; Escudier, B.; Motzer, R. J.; Albiges, L.; Voss, M. H.
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Estimand framework: Are we asking the right questions? A case study in the solid tumor setting
    Journal Article

    Casey, M.; Degtyarev, E.; Lechuga, M. J.; Aimone, P.; Ravaud, A.; Motzer, R. J.; Liu, F.; Stalbovskaya, V.; Tang, R.; Butler, E.; more...
    Pharmaceutical Statistics (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma
    Journal Article

    Choueiri, T. K.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Zurawski, B.; Oyervides Juárez, V. M.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save